OBJECTIVES: This study investigated the role of religion/spirituality (R/S) and coping in quality of life (QOL) in 129 women immediately prior to a course of adjuvant chemotherapy for ovarian cancer. METHODS: Participants completed the COPE, the Functional Assessment of Cancer Therapy-Ovarian (FACT-O), and the Systems of Belief Inventory-15R (SBI-15R). Women averaged 58.9 years of age (SD = 11.5) and were primarily Caucasian (86%), married (74%), and had received at least some college education (67%). Eighty-five percent of the participants had stage III or IV ovarian cancer at study entry. RESULTS: Correlational analyses revealed that R/S was associated with active coping (r = 0.23, P = 0.022), overall QOL (r = 0.25, P = 0.012), emotional and functional well-being (r = 0.24, P = 0.014 and r = 0.28, P = 0.004), and fewer ovarian cancer-specific concerns (r = 0.27, P = 0.006). In addition, active coping was related to overall QOL (r = 0.22, P = 0.029) and social and functional well-being (r = 0.20, P = 0.042 and r = 0.33, P = 0.001). Tests of mediation between these variables suggested that the positive associations between R/S and functional well-being and R/S and overall QOL were mediated through the use of active coping. CONCLUSION: Future studies are needed to better understand the complex relationships between R/S, coping, and QOL throughout the ovarian cancer treatment experience.
OBJECTIVES: This study investigated the role of religion/spirituality (R/S) and coping in quality of life (QOL) in 129 women immediately prior to a course of adjuvant chemotherapy for ovarian cancer. METHODS:Participants completed the COPE, the Functional Assessment of Cancer Therapy-Ovarian (FACT-O), and the Systems of Belief Inventory-15R (SBI-15R). Women averaged 58.9 years of age (SD = 11.5) and were primarily Caucasian (86%), married (74%), and had received at least some college education (67%). Eighty-five percent of the participants had stage III or IV ovarian cancer at study entry. RESULTS: Correlational analyses revealed that R/S was associated with active coping (r = 0.23, P = 0.022), overall QOL (r = 0.25, P = 0.012), emotional and functional well-being (r = 0.24, P = 0.014 and r = 0.28, P = 0.004), and fewer ovarian cancer-specific concerns (r = 0.27, P = 0.006). In addition, active coping was related to overall QOL (r = 0.22, P = 0.029) and social and functional well-being (r = 0.20, P = 0.042 and r = 0.33, P = 0.001). Tests of mediation between these variables suggested that the positive associations between R/S and functional well-being and R/S and overall QOL were mediated through the use of active coping. CONCLUSION: Future studies are needed to better understand the complex relationships between R/S, coping, and QOL throughout the ovarian cancer treatment experience.
Authors: Andrea L Canada; George Fitchett; Patricia E Murphy; Kevin Stein; Kenneth Portier; Corinne Crammer; Amy H Peterman Journal: J Behav Med Date: 2012-07-03
Authors: Sharon L Manne; Shannon Myers-Virtue; Deborah Kashy; Melissa Ozga; David Kissane; Carolyn Heckman; Stephen C Rubin; Norman Rosenblum Journal: Cancer Nurs Date: 2015 Sep-Oct Impact factor: 2.592
Authors: Eva Mazzotti; Federica Mazzuca; Claudia Sebastiani; Alessandro Scoppola; Paolo Marchetti Journal: Support Care Cancer Date: 2010-11-25 Impact factor: 3.603
Authors: Patricia G Moorman; Nadine J Barrett; Frances Wang; J Anthony Alberg; Elisa V Bandera; J B Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Linda E Kelemen; Lauren C Peres; Edwards S Peters; A G Schwartz; Paul D Terry; Sydnee Crankshaw; Sarah E Abbott; Joellen M Schildkraut Journal: J Womens Health (Larchmt) Date: 2018-11-27 Impact factor: 2.681
Authors: Andrea C Phelps; Paul K Maciejewski; Matthew Nilsson; Tracy A Balboni; Alexi A Wright; M Elizabeth Paulk; Elizabeth Trice; Deborah Schrag; John R Peteet; Susan D Block; Holly G Prigerson Journal: JAMA Date: 2009-03-18 Impact factor: 56.272